Skip to main content
. 2023 Oct 4;14:1270796. doi: 10.3389/fendo.2023.1270796

Figure 1.

Figure 1

Kaplan Meier curves showing a clear and significant separation of disease-free survival (DFS) between different ATA stages (A) and different TNM stages (B). There was no statistically significant difference between BRAFV600E-positive and wild BRAF tumors (C) but there are statistically significant differences between TERT promoter mutation-positive tumors and tumors with wild type TERT promoter in the absence (D) or presence (E) of concomitant BRAFV600E mutation.